Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $307.9700 (1.69%) ($300.0000 - $308.3900) on Tue. Jul. 9, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.08% (three month average) | RSI | 53 | Latest Price | $307.9700(1.69%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN declines -0.6% a day on average for past five trading days. | Weekly Trend | REGN declines -0.6% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(58%) XLV(47%) IVW(41%) IWF(40%) QQQ(40%) | Factors Impacting REGN price | REGN will decline at least -1.04% in a week (0% probabilities). VIXM(-25%) VXX(-11%) IFRA(-7%) TLT(-6%) TIP(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.04% (StdDev 2.08%) | Hourly BBV | 0 () | Intraday Trend | 2.3% | | | |
|
Resistance Level | $310.96 | 5 Day Moving Average | $310.46(-0.8%) | 10 Day Moving Average | $310.97(-0.96%) | 20 Day Moving Average | $310.96(-0.96%) | To recent high | -24.6% | To recent low | 2.8% | Market Cap | $32.654b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |